CYP19
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea (NCT01137136) | Samsung Medical Center | 2010-06-01 |
Track CYP19 automatically
Every clearance here is in the API, with alerts when new ones post.